| |
| |
|
| Insider
Information: |
Dere Willard H |
| Relationship: |
|
| City: |
Thousand Oaks |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
164,053 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,241,724 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
164,053 |
|
|
| Total
Value |
$6,241,724 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Officer |
2004-12-13 |
9,550 |
|
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-21 |
32,300 |
2016-07-15 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2017-06-20 |
0 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
Premium* |
|
|
Seres Therapeutics, Inc. |
MCRB |
Director |
2022-07-05 |
31,746 |
2022-07-05 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2024-01-02 |
39,182 |
2023-04-03 |
0 |
Premium* |
|
|
Metagenomi, Inc. |
MGX |
|
2024-02-08 |
51,275 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
30 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,217 |
22,059 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,011 |
33,070 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,112 |
39,182 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,720 |
32,300 |
0 |
- |
|
| AMGN |
Amgen Inc |
Sr. V.P., Global Dev & CMOOffi |
• – – |
2004-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,550 |
|
- |
|
30 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
